Helicobacter pylori infection in interleukin-4-deficient and transgenic mice

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 10, 1999, Pages 987-992

  Chen, W ^a   Shu, D ^a   Chadwick, V S ^a  

^a Wakefield Hospital   (New Zealand)

Author keywords

Cytokines; Gastritis; Helicobacter pylori; Inflammation; Interleukin 4

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HELPER CELL; HOST RESISTANCE; IMMUNE RESPONSE; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; STOMACH MUCOSA; TRANSGENIC MOUSE;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; STATISTICS, NONPARAMETRIC;

EID: 0032693595     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750025084     Document Type: Article

References (37)

1. 1. Karttunen R, Karttunen T, Ekre H-PT, MacDonald T. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995; 36:341-5.
2. 2. Blaser M, Parsonnet J. Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
3. 3. Telford JL, Covacci A, Rappuoli R, Ghiara P. Immunobiology of Helicobacter pylori infection. Curr Opin Immunol 1997;9: 498-503.
4. 4. Wadstrom T. An update on Helicobacter pylori. Curr Opinion Gastroenterol 1995;11:69-75.
5. 5. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection. Scand J Gastroenterol 1995;30: 1153-9.
6. 6. Badger K, Wyatt JI, Heatley RV. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut 1997; 40:739-44.
7. 7. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, et al. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998;42:609-17.
8. 8. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor a and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
9. 9. Crabtree JE, Farmery SM. Helicobacter pylori and gastric mucosal cytokines: evidence that CagA-positive strains are more virulent. Lab Invest 1995;73:742-5.
10. 10. Noach L, Bosma N, Jansen J, Hoek F, van Deventer S, Tytgat G. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29:425-9.
11. 11. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997;41:442-51.
12. 12. Ishihara S, Fukuda R, Fukumoto S. Cytokine gene expression in the gastric mucosa: its role in chronic gastritis. J Gastroenterol 1996;31:485-90.
13. 13. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991;77:1859-70.
14. 14. Asherson GL, Dieli F, Sireci G, Salerno A. Role of IL-4 in delayed type hypersensitivity. Clin Exp Immunol 1996;103:1-4.
15. 15. Choi P, Reiser H. IL-4: role in disease and regulation of production. Clin Exp Immunol 1998;113:317-9.
16. 16. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 1997;113:1848-57.
17. 17. Fan X, Yakoob J, Fan X, Keeling P. Effect of IL-4 on peripheral blood lymphocyte proliferation: implication in immunopathogenesis of H. pylori infection. Immunol Lett 1995;48:45-8.
18. 18. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995;267:1655-8.
19. 19. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection. Gastroenterology 1997;112:1386-97.
20. 20. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the inurine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-8.
21. 21. Erb KJ, Holtschke T, Muth K, Horak I, Schimpl A. T cell subset distribution and B cell hyperreactivity in mice expressing interleukin-4 under the control of major histocompatibility complex class I regulatory sequences. Eur J Immunol 1994;24: 1143-7.
22. 22. Erb KJ, Ruger B, von Brevern M, Ryffel B, Schimpl A, Rivett K. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 1997;185:329-39.
23. 23. Covacci A, Censini S, Bugnoli M, Petracca R, Butroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
24. 24. Chen W, Harp J, Harmsen A, Havell E. Interferon-gamma functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect Immun 1993;61: 3548-51.
25. 25. Hazell SL, Borody TJ, Gal A, Lee A. Campylobacter pyloridis gastritis. I. Detection of ureasc as a marker of bacterial colonization and gastritis. Am J Gastroenterol 1987;82:292-6.
26. 26. Chen W, Havell E, Gigliotti F, Harmsen A. Interleukin-6 production in a murine model of Pneumocytis carinii pneumonia: relation to resistance and inflammatory response. Infect Immun 1993;61:97-102.
27. 27. Burstein HJ, Tepper RI, Leder P, Abbas AK. Humoral immune functions in IL-4 transgenic mice. J Immunol 1991;147:2950-6.
28. 28. Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 1990; 62:457-67.
29. 29. Sommer F, Faller G, Konturek P, Kirchner T, Hahn EG, Zeus J, et al. Antrum-and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun 1998;66:5543-6.
30. 30. Mohammadi M, Czinn S, Redline R, Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 1996;156:4729-38.
31. 31. Lee CK, Weltzin R, Thomas WD Jr, Kleanthous H, Ermak TH, Soman G, et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995;172:161-72.
32. 32. Lee A, Buck F. Vaccination and mucosal responsee to Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10: 129-38.
33. 33. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa YI, et al. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 1999;67:279-85.
34. 34. Ferrero RL, Thiberge JM, Huerre M, Labigne A. Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SSI) infection. Infect Immun 1998;66:1349-55.
35. 35. Figura N, Cetta F, Angelico M, Montalto G, Cetta D, Pacenti L, et al. Most Helicobacter pylori-infected patients have specific antibodies, and some also have H-pylori antigens and genomic material in bile - Is it a risk factor for gallstone formation? Dig Dis Sci 1998;43:854-62.
36. 36. Danon SJ, O'Rourke JL, Moss ND, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 1995;108:1386-95.
37. 37. Radcliff F, Ramsay A, Lee A. Is a mixed Th1/Th2 response necessary for effective immunity against Helicobacter? Gut 1997;41(SI):A60.